Tower Research Capital (TRC)’s TriSalus Life Sciences TLSI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $534 | Buy |
+98
| New | +$534 | ﹤0.01% | 5001 |
|
|
2025
Q1 | – | Sell |
-555
| Closed | -$2.78K | – | 5784 |
|
|
2024
Q4 | $2.78K | Sell |
555
-1,148
| -67% | -$5.75K | ﹤0.01% | 4775 |
|
|
2024
Q3 | $7.85K | Sell |
1,703
-4,217
| -71% | -$19.4K | ﹤0.01% | 4011 |
|
|
2024
Q2 | $32.7K | Buy |
5,920
+4,378
| +284% | +$24.2K | ﹤0.01% | 3420 |
|
|
2024
Q1 | $15K | Sell |
1,542
-431
| -22% | -$4.2K | ﹤0.01% | 3263 |
|
|
2023
Q4 | $16.7K | Buy |
+1,973
| New | +$16.7K | ﹤0.01% | 3772 |
|
|
2022
Q1 | – | Sell |
-1,336
| Closed | -$13K | – | 6554 |
|
|
2021
Q4 | $13K | Buy |
1,336
+643
| +93% | +$6.26K | ﹤0.01% | 4205 |
|
|
2021
Q3 | $7K | Buy |
+693
| New | +$7K | ﹤0.01% | 4674 |
|
|
2021
Q2 | – | Sell |
-100
| Closed | -$1K | – | 5841 |
|
|
2021
Q1 | $1K | Buy |
+100
| New | +$1K | ﹤0.01% | 5219 |
|